We can't find the internet
Attempting to reconnect
13877.1;10 PFLS-LS
Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases
Résumé
Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases
Textes supplémentaires
Abstract
Non-invasive, nuclear imaging techniques such as positron emission tomography (PET) are crucial for cancer diagnosis, treatment planning and monitoring. The folate receptor (FR) is a promising cancer-related target because of its overexpression in a wide variety of tumor types. We will test the first PET-folate tracer in a pilot study in patients. The novel radiotracer is expected to be of major clinical and health economical relevance as it serves for diagnostic purposes and also for identification of patients, who may profit from FR-targeting therapies.
Participants
Roger Schibli
Kontaktperson
roger.schibli@pharma.ethz.ch
ETH Zürich Roger Schibli Wolfgang-Pauli-Strasse 10 Institute of Pharmaceutical Science 8093 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2012-08-31
- Date de fin
- 2015-11-11
- Coûts totaux approuvés
- CHF 142080.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Nicht aufteilbare / nicht zuteilbare Forschung
Disciplines de recherche
- P004 Biochemistry, Metabolism 100.0%